Fingerprint
Dive into the research topics of 'Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
Immune Tolerance Network (ITN) T1DAL Study Group
Research output: Contribution to journal › Article › peer-review
212
Scopus
citations